Tissue histopathology, clinical chemistry and behaviour of adult comt‐gene‐disrupted mice
- 22 July 2003
- journal article
- research article
- Published by Wiley in Journal of Applied Toxicology
- Vol. 23 (4) , 213-219
- https://doi.org/10.1002/jat.909
Abstract
Catechol‐O‐methyltransferase (COMT) enzyme is a widely distributed enzyme that catalyses O‐methylation of catecholamines and other compounds having a catechol structure. Because there has been some concern about the consequences of a low COMT activity in the development of oestrogen‐dependent cancers and because one of the COMT inhibitors, tolcapone, has caused serious liver injuries in Parkinsonian patients, the histopathology and clinical chemistry of Comt‐gene‐disrupted mice were studied at the age of 12 months. Owing to the high COMT activities in liver and kidney and the role of COMT in the metabolism of catechol oestrogens, special emphasis was given to the histology of the liver, kidney and oestrogen‐dependent organs such as mammary glands and uterus.The mice of both heterozygous and homozygous genotypes appear to be physically healthy and fertile. Diurnal motility rhythm and behaviour in measuring anxiety and depression were equal in all genotypes. At the age of 12 months, the body weight of homozygous mice was 7–9% lower than that of the other groups. This was reflected in histology as a diminished incidence of vacuolation of liver cells (fatty change). Macroscopic pathology and histopathology revealed no abnormal findings in any COMT genotype. The values of some clinical chemistry parameters, such as alkaline phosphatase, alanine aminotransferase, urea, glucose, calcium and proteins, were at a higher level in homozygous animals compared with the wild‐type mice. However, all the values remained within the normal physiological range, and the differences in enzyme levels between genotypes were not reflected as histopathological findings in the relevant organs. No changes in haematological parameters or plasma catecholamine concentrations were noted but plasma 3,4‐dihydroxyphenylethylene glycol levels were high in COMT null mice.The results suggest that the full or 50% lack of Comt gene as such is not associated with any toxic consequences. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Effect of Dopamine Uptake Inhibition on Brain Catecholamine Levels and Locomotion in Catechol-O-methyltransferase-Disrupted MiceThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Tolcapone and fulminant hepatitisThe Lancet, 1998
- Functional role of estrogen metabolism in target cells: review and perspectivesCarcinogenesis: Integrative Cancer Research, 1998
- Distribution of catechol-O-methyltransferase enzyme in rat tissues.Journal of Histochemistry & Cytochemistry, 1994
- Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake InhibitorsJournal of Neurochemistry, 1993
- Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2Genomics, 1992
- Plasma 3, 4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4- hydroxyphenylglycol (MHPG) are insensitive indicators of α2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteersLife Sciences, 1991
- Dopamine transporter: Solubilization from dog caudate nucleusSynapse, 1989
- Reference range data base for serum chemistry and hematology values in laboratory animalsJournal of Toxicology and Environmental Health, 1986
- METABOLISM OF PROLACTIN IN MICE WITH A HIGH INCIDENCE OF MAMMARY TUMOURS: EVIDENCE FOR GREATER CONVERSION INTO A NON-IMMUNOASSAYABLE FORMJournal of Endocrinology, 1979